Drugs / KAZ954
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04237649 | Feb 2020 → Sep 2023 | cancer | Novartis Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KAZ954 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04237649 ↗ |